Literature DB >> 36243792

Aloe polysaccharide promotes osteogenesis potential of adipose-derived stromal cells via BMP-2/Smads and prevents ovariectomized-induced osteoporosis.

Xue-Wei Yao1, He-Dong Liu1, Mao-Xian Ren1, Tian-Lin Li1, Wen-Kai Jiang1, Zhi Zhou1, Zhi-Yi Liu1, Min Yang2.   

Abstract

BACKGROUND: Aloe polysaccharide (AP) is a type of an active macromolecule of Aloe vera, which contributes to its function. However, whether AP possesses anti-osteoporosis properties is unknown.
METHODS: Adipose-derived stromal cells were treated with different concentrations of AP. Early and late osteogenesis were, respectively, evaluated by ALP and Alizarin Red S staining. The effect of AP on the processes of adipogenesis inhibition in ADSCs was analyzed by oil red O staining. Western blot was used to assess the expression of osteogenic and adipogenic related factors. Then, Noggin was administered to further confirm the mechanism by which AP promotes the osteogenesis of ADSCs. Finally, 40 female SD rats were classified into a bilateral laparotomy group (Sham group) and three bilateral ovariectomy groups: OVX group, OVX + AP group, and OVX + AP + Noggin group. The bilateral rat femurs were collected to perform micro-CT scanning, HE, Masson trichrome, and Oil red O staining.
RESULTS: The results indicated that AP could increase ALP expression and calcium deposition. Through molecular mechanisms, AP promotes the protein expression of COL1A1, OPN, and ALP in ADSCs, but downregulates the expression of PPARγ. Also, AP directs ADSCs' fate by stimulating the BMP2/Smads signaling pathway. In vivo, the rat AP-treated had more trabecular bone than the OVX rat, indicating partial protection from cancellous bone loss after treatment with AP.
CONCLUSION: Our results show that AP may promote osteogenesis of ADSCs through BMP-2/Smads signaling pathway and inhibits lipogenic differentiation. Thus, AP might be a promising alternative medicine to treat postmenopausal osteoporosis.
© 2022. The Author(s).

Entities:  

Keywords:  Adipose-derived stromal cells; Aloe polysaccharide; BMP-2/Smads signaling pathway; Osteoporosis

Year:  2022        PMID: 36243792     DOI: 10.1007/s11033-022-08003-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  32 in total

1.  Isolation and characterization of novel protein with anti-fungal and anti-inflammatory properties from Aloe vera leaf gel.

Authors:  Swagata Das; Biswajit Mishra; Kamaldeep Gill; Md Saquib Ashraf; Abhay Kumar Singh; Mou Sinha; Sujata Sharma; Immaculata Xess; Krishna Dalal; Tej Pal Singh; Sharmistha Dey
Journal:  Int J Biol Macromol       Date:  2010-10-01       Impact factor: 6.953

2.  HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis.

Authors:  Yoshiteru Miyauchi; Yuiko Sato; Tami Kobayashi; Shigeyuki Yoshida; Tomoaki Mori; Hiroya Kanagawa; Eri Katsuyama; Atsuhiro Fujie; Wu Hao; Kana Miyamoto; Toshimi Tando; Hideo Morioka; Morio Matsumoto; Pierre Chambon; Randall S Johnson; Shigeaki Kato; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-10       Impact factor: 11.205

3.  The no-observed-adverse-effect level (NOAEL) of baby aloe powder (BAP) for nutraceutical application based upon toxicological evaluation.

Authors:  Seung Jun Kwack; Seon-Gil Do; Young Woo Kim; Yeon-Joo Kim; Hyo-Min Gwak; Hyun Jong Park; Taehyun Roh; Min Kyung Shin; Seong Kwang Lim; Hyung Sik Kim; Byung-Mu Lee
Journal:  J Toxicol Environ Health A       Date:  2014

4.  Polygonatum Sibiricum Polysaccharide Promotes Osteoblastic Differentiation Through the ERK/GSK-3β/β-Catenin Signaling Pathway In Vitro.

Authors:  Xiaoming Peng; Jichen He; Jinmin Zhao; Yunle Wu; Xiongzhi Shi; Li Du; Mengni Nong; Shaohui Zong; Gaofeng Zeng
Journal:  Rejuvenation Res       Date:  2017-08-03       Impact factor: 4.663

Review 5.  Clinical Practice. Postmenopausal Osteoporosis.

Authors:  Dennis M Black; Clifford J Rosen
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

6.  Influence of pH on osteoclasts treated with zoledronate and alendronate.

Authors:  Francisco Javier Manzano-Moreno; Javier Ramos-Torrecillas; Elvira de Luna-Bertos; Rebeca Illescas-Montes; Timothy R Arnett; Concepción Ruiz; Olga García-Martínez
Journal:  Clin Oral Investig       Date:  2018-06-06       Impact factor: 3.573

7.  The wound-healing effect of a glycoprotein fraction isolated from aloe vera.

Authors:  S W Choi; B W Son; Y S Son; Y I Park; S K Lee; M H Chung
Journal:  Br J Dermatol       Date:  2001-10       Impact factor: 9.302

8.  Antioxidant activity and preventive effect of aqueous leaf extract of Aloe Vera on gentamicin-induced nephrotoxicity in male Wistar rats.

Authors:  A Baradaran; H Nasri; M Nematbakhsh; M Rafieian-Kopaei
Journal:  Clin Ter       Date:  2014

Review 9.  Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

Authors:  E Hernlund; A Svedbom; M Ivergård; J Compston; C Cooper; J Stenmark; E V McCloskey; B Jönsson; J A Kanis
Journal:  Arch Osteoporos       Date:  2013-10-11       Impact factor: 2.617

10.  Risk of atypical femoral fracture during and after bisphosphonate use.

Authors:  Jörg Schilcher; Veronika Koeppen; Per Aspenberg; Karl Michaëlsson
Journal:  Acta Orthop       Date:  2015-01-13       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.